Exact Mass: 434.1734108

Exact Mass Matches: 434.1734108

Found 500 metabolites which its exact mass value is equals to given mass value 434.1734108, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Flupentixol

cis-(Z)-Flupenthixol

C23H25F3N2OS (434.1639596)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AF - Thioxanthene derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

Cycloartocarpin

1,3-dihydroxy-8-methoxy-2-[(1E)-3-methylbut-1-en-1-yl]-11-(2-methylprop-1-en-1-yl)-11,12-dihydro-5,10-dioxatetraphen-12-one

C26H26O6 (434.17292960000003)

Cycloartocarpin is found in fruits. Cycloartocarpin is a constituent of Artocarpus heterophyllus (jackfruit). Constituent of Artocarpus heterophyllus (jackfruit). Cycloartocarpin is found in jackfruit and fruits.

Auriculin

5-hydroxy-3-(2-hydroxy-4-methoxyphenyl)-8,8-dimethyl-10-(3-methylbut-2-en-1-yl)-4H,8H-pyrano[3,2-g]chromen-4-one

C26H26O6 (434.17292960000003)

Flupentixol

2-(4-{3-[2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl}piperazin-1-yl)ethan-1-ol

C23H25F3N2OS (434.1639596)

Luseogliflozin

2-{5-[(4-ethoxyphenyl)methyl]-2-methoxy-4-methylphenyl}-6-(hydroxymethyl)thiane-3,4,5-triol

C23H30O6S (434.1763)

Olaparib

4-{[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorophenyl]methyl}phthalazin-1-ol

C24H23FN4O3 (434.17540999999994)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XK - Poly (adp-ribose) polymerase (parp) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

7-O-Ethylmorroniside

7-O-ethyl-morroniside

C19H30O11 (434.178803)

7-O-ethyl-morroniside is a natural product found in Cornus officinalis with data available.

Mundulone

(-) -3,4-Dihydro-3-hydroxy-7- (5-methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl) -2,2-dimethyl-2H,6H-benzo [ 1,2-b:5,4-b ] dipyran-6-one

C26H26O6 (434.17292960000003)

isoartocarpin

3,8-Dihydroxy-10-methoxy-9- (3-methyl-1-butenyl) -6- (2-methyl-1-propenyl) -6H,7H- [ 1 ] benzopyrano [ 4,3-b ] [ 1 ] benzopyran-7-one

C26H26O6 (434.17292960000003)

Secologanin dimethyl acetal

(-)-Secologanin dimethyl acetal

Macaflavone II

C26H26O6 (434.17292960000003)

bulgarialactone C

C26H26O6 (434.17292960000003)

Scandenin

4-Hydroxy-3- (4-hydroxyphenyl) -5-methoxy-8,8-dimethyl-6- (3-methyl-2-butenyl) -2H,8H-benzo [ 1,2-b:3,4-b ] dipyran-2-one

C26H26O6 (434.17292960000003)

Ferrugin

8bH-Cyclopenta[b]benzofuran-1,8b-diol, 1,2,3,3a-tetrahydro-6,8-dimethoxy-3a-(4-methoxyphenyl)-3-phenyl-, (1R,3S,3aR,8bS)-

C26H26O6 (434.17292960000003)

C26H26O6 (434.17292960000003)

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carboxybutanamido]-3-hydroxypropanamido]pentanedioic acid

C16H26N4O10 (434.16488560000005)

Thr Trp Glu

C20H26N4O7 (434.1801406)

Asp Ala Thr Glu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]-3-hydroxybutanamido]pentanedioic acid

C16H26N4O10 (434.16488560000005)

Glu Thr Ala Asp

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-carboxybutanamido]-3-hydroxybutanamido]propanamido]butanedioic acid

C16H26N4O10 (434.16488560000005)

Ala Ile Cys Glu

(2S)-2-[(2R)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-sulfanylpropanamido]pentanedioic acid

C17H30N4O7S (434.183511)

Trp Glu Thr

C20H26N4O7 (434.1801406)

Trp Thr Glu

C20H26N4O7 (434.1801406)

7α-O-Ethylmorroniside

7|A-O-Ethylmorroniside

C19H30O11 (434.178803)

Fluvoxamine maleate

C19H25F3N2O6 (434.1664626)

5-hydroxy-7-(4-hydroxy-2-methoxyphenyl)-2,2-dimethyl-10-(3-methylbut-2-enyl)pyrano[3,2-g]chromen-6-one

NCGC00347545-02!5-hydroxy-7-(4-hydroxy-2-methoxyphenyl)-2,2-dimethyl-10-(3-methylbut-2-enyl)pyrano[3,2-g]chromen-6-one

C26H26O6 (434.17292960000003)

C20H26N4O7 (434.1801406)

Ile Met Asp Gly

(3S)-3-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C17H30N4O7S (434.183511)

Ile Met Gly Asp

(2S)-2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-(methylsulfanyl)butanamido]acetamido}butanedioic acid

C17H30N4O7S (434.183511)

Ile Pro Cys Cys

(2R)-2-[(2R)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H30N4O5S2 (434.165753)

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C17H30N4O7S (434.183511)

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxypropanamido]-3-carboxypropanamido]butanedioic acid

C16H26N4O10 (434.16488560000005)

Val Val Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-sulfanylpropanamido]butanedioic acid

C17H30N4O7S (434.183511)

Val Val Asp Cys

(3S)-3-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C17H30N4O7S (434.183511)

Cycloartocarpin A

C26H26O6 (434.17292960000003)

Idebenone Metabolite (Benzenedecanoic acid, 2-hydroxy-3,4-dimethoxy-6-methyl-5-(sulfooxy)-)

C19H30O9S (434.16104500000006)

1,4-bis-triethoxysilanyloxy-benzene

C18H34O8Si2 (434.1792124)

Glisolamide

N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-1,2-oxazole-3-carboxamide

C20H26N4O5S (434.16238260000006)

C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent

1-[1-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-prolyl]-D-proline

C25H26N2O5 (434.18416260000004)

Luseogliflozin

C23H30O6S (434.1763)

A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BK - Sodium-glucose co-transporter 2 (sglt2) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent C471 - Enzyme Inhibitor > C98083 - SGLT2 Inhibitor

Z-Glu(OtBu)-OSu

C21H26N2O8 (434.1689076)

1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid bis(2-methoxyethyl) ester

C21H26N2O8 (434.1689076)

Cevimeline hydrochloride hemihydrate

C20H35ClN2O2S2 (434.182836)

CL-216942

C22H23ClN8 (434.1734108)

Fmoc-Pro-Pro-OH

C25H26N2O5 (434.18416260000004)

Adapalene (sodium salt)

C28H27NaO3 (434.18577920000007)

[(1R,5R)-3-(bromomethylidene)-5-[tert-butyl(dimethyl)silyl]oxycyclohexyl]oxy-tert-butyl-dimethylsilane

C19H39BrO2Si2 (434.1671814)

Fluvoxamine maleat

(E)-But-2-enedioic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine

C19H25F3N2O6 (434.1664626)

D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065689 - Cytochrome P-450 CYP2C19 Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors D049990 - Membrane Transport Modulators C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

Benzoic acid, 3-((S)-(4-((4-acetyl-3-hydroxy-2-propylphenoxy)methyl)phenyl)hydroxymethyl)-

C26H26O6 (434.17292960000003)

N-(4-(((4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-yl)methyl)carbamoyl)phenyl)furan-2-carboxamide

C25H26N2O5 (434.18416260000004)

N-(2-Deoxyguanosin-8-yl)-4-aminobiphenyl

C22H22N6O4 (434.1702452)

Niperotidine

(E)-1-N-(1,3-Benzodioxol-5-ylmethyl)-1-N-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-2-nitroethene-1,1-diamine

C20H26N4O5S (434.16238260000006)

A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H₂-receptor antagonists

Olaparib

Olaparib (AZD2281, Ku-0059436)

C24H23FN4O3 (434.17540999999994)

Niperotidina

C20H26N4O5S (434.16238260000006)

A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H₂-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist

3,8-dihydroxy-10-methoxy-9-[(E)-3-methylbut-1-enyl]-6-(2-methylprop-1-enyl)-6H-chromeno[4,3-b]chromen-7-one

C26H26O6 (434.17292960000003)

Ochrocarpin D

C26H26O6 (434.17292960000003)

A furanocoumarin that is 2H-furo[2,3-h]chromen-2-one substituted by a hydroxy group at position 5, 2-methoxypropan-2-yl group at position 8, a 2-methylbutanoyl group at position 6 and a phenyl group at position 4. Isolated from the bark of Ochrocarpos punctatus, it exhibits cytotoxicity against the A2780 ovarian cancer cell line.

2-[(2,4-dimethoxyphenyl)methyl-methylamino]-N-(2-methoxy-3-dibenzofuranyl)acetamide

C25H26N2O5 (434.18416260000004)

4-Methoxy-3-nitrobenzaldehyde (4-anilino-6-pyrrolidin-1-yl-1,3,5-triazin-2-yl)hydrazone

C21H22N8O3 (434.1814782)

artoindonesianin E1

Trp-Glu-Thr

C20H26N4O7 (434.1801406)

Trp-Thr-Glu

C20H26N4O7 (434.1801406)

3-(2-Methoxy-4-hydroxyphenyl)-5-hydroxy-8,8-dimethyl-10-prenyl-4H,8H-benzo[1,2-b:5,4-b]dipyran-4-one

C26H26O6 (434.17292960000003)

ST 19:1;O6;S

C19H30O9S (434.16104500000006)

ST 23:5;O3;S

C23H30O6S (434.1763)

CP-31398 (dihydrochloride)

C22H28Cl2N4O (434.1640058)

CP-31398 dihydrochloride stabilizes the active conformation of p53 and promotes p53 activity in cancer cell lines with mutant or wild-type p53[1][2][3].

(2s,3r,5s,6r)-10,12-dimethoxy-6-(4-methoxyphenyl)-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-2,3-diol

C26H26O6 (434.17292960000003)

3-[2-(hydroxymethyl)-3-methoxyphenyl]-2-(1h-indol-6-yl)-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

C28H22N2O3 (434.16303419999997)

(1r,4s,7s,9s)-4-benzyl-9,14-dihydroxy-1-(2-methylbut-3-en-2-yl)-5-oxa-2,16-diazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-triene-3,6-dione

C25H26N2O5 (434.18416260000004)

5-hydroxy-3-(1-hydroxy-3-methylbut-2-en-1-yl)-2-(4-methoxyphenyl)-8,8-dimethylpyrano[2,3-h]chromen-4-one

C26H26O6 (434.17292960000003)

(?)-(10s)-ligulacephalin c

C26H26O6 (434.17292960000003)

{"Ingredient_id": "HBIN000202","Ingredient_name": "(?)-(10s)-ligulacephalin c","Alias": "NA","Ingredient_formula": "C26H26O6","Ingredient_Smile": "CC1(CCC(=C)C2=C1C3=CC(=C(C=C3O2)OC)OC)C4=CC5=CC(=C(C=C5O4)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "12805","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

5,4'-dihydroxy-8-(3,3-dimethylallyl)-2''-me-thoxyisopropylfurano[4,5:6,7]isoflavone

C26H26O6 (434.17292960000003)

C28H22N2O3 (434.16303419999997)

(13s)-13-(5,6-dimethoxy-1-benzofuran-2-yl)-4,5-dimethoxy-13-methyl-10-methylidene-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2,4,6-tetraene

C26H26O6 (434.17292960000003)